Navigation Links
Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date

There are about three severe, potentially fatal genetic diseases which damage aortas leaving them so flimsy that they can rupture in pregnancy and labor or even lesser //activities, often without warning. Beta blockers, curbing exercise, proactive blood vessel surgery and other approaches can be helpful, but their usefulness varies according to which disease and when they're offered.

Now a large follow-up study of more than 50 families by a multi-institutional team led by Johns Hopkins scientists should bring better guidelines for treating the disorders. The work, published August 24 in The New England Journal of Medicine, closely compares patients having one of two types of the lesser known Loeys-Dietz syndrome or Ehlers-Danlos syndrome with better-understood Marfan syndrome. It stresses the importance of comprehensive clinical evaluations when diagnosing the diseases.

People with Loeys-Dietz syndrome have wideset eyes, a cleft palate or split uvula (the tissue that hangs down in the back of the throat), and a convoluted arrangement of the body's blood vessels, in addition to aggressive swelling of the aorta. In these patients, the aorta breaks at a much smaller size than it does in people with Marfan syndrome or most other causes of aortic aneurysm.

Marfan and Ehlers-Danlos syndromes both are similar heritable conditions with overlapping symptoms that affect the connective tissue, the tissue that holds the body together. Marfan syndrome can affect many body systems, including the skeleton, eyes, heart and blood vessels, nervous system, skin and lungs. The vascular variant of Ehlers-Danlos also affects skin, muscles and ligaments and causes hypermobility of joints and fragile blood vessels that tear easily.

"This study shows that both clinical and molecular analyses can distinguish patients with Loeys-Dietz syndrome from those with either Marfan syndrome or vascular Ehlers-Danlos syndrome," says Harry Dietz, M.D., director
'"/>




Page: 1 2 3

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
(Date:12/5/2009)... Wind Turbines are popping ...g from growing mushrooms, making wine to keeping p...B) December 5, 2009 -- Who would have thought that...rom Wind Turbines? Wind Inc. of Fort Worth, Texas ... end users, not wind farms. "Using a technology d...
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 Allied World ...ay announced that Scott Carmilani,President and Ch... Vice,President and Chief Corporate Strategy Offic....S. Financial Services Conference being held at th... on Tuesday, December 8, 2009. ,, About Allied...
(Date:12/4/2009)... , ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief...elected as a finalist for the "Chief Innovation Of...ness with the power of cloud computing. Appy Award...e usage of Salesforce CRM or the Force.com platfor...eir sales, marketing, partner, service, support or...
(Date:12/4/2009)...Working with mice, scientists at Johns Hopkins pub...shown that a protein made by a gene called "Twist"...y distinguish stem cells that drive aggressive, me...lls. , Building on recent work suggesting that it...east tumors that drives breast cancer, scientists ...
(Date:12/4/2009)...comes same whether procedure done immediately or 3... 4 (HealthDay News) -- Timing of surgical repair o...s may not affect patient outcome, a new study has ...om traumatic knee dislocations that can occur in h...ptimal time to perform surgery to repair these inj...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
... AFL ) announced today that it will make a present...y-Fourth Annual Strategic Decisions Conference,200...loninger III will,represent Aflac Incorporated, an...ny,s outlook for 2008 and its strategy for,growth ...
...stopher Georgacas and Mark Mi...At its Board Meeting earlier today,the Board of Di...llion in,new grants to expand QUITPLAN(R) Services...ard also welcomed three new,Board Members, the Hon...
... allergy symptoms, PROVIDENCE, R.I., May 21 Apri......sneezes?, For those allergy sufferers out ther...the end of cold weather and snow is certainly welc... Month,and CleanBrands, creators of The World,s Cl...
...erations and new agr...TC,Bulletin Board: ISCR), a leading distributor of...ll, life-saving prescription drugs and a developer...t,highlights include:, -- Revenue grew by 258% i...
...reast Cancer Research Fund, WEST CHESTER, Pa., Ma...y when leading multimedia retailer QVC(R) once aga...7 at 1 AM (ET) and 6 PM,(ET). These two one-hour p...newscom.com/cgi-bin/prnh/20070923/NESU001LOGO ), ...
... played,host to nearly 300 guests at its PowerPlex...ent speaker who provided a poignant report on the ...newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ), ...His remarks included the findings of a survey cond...
Other Medicine News:Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 3Health News:Spring Allergies Got You Down? Try Some of These Drug-Free Options 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:A Touch of Pink Never Looked So Good 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 3
(Date:12/3/2009)...WARRENDALE, Pa., Dec. 3 Radiology imaging leader ...ntegration capabilities at the November 2009 Radio...nnect.PACS(TM) product, enabling the first radiol...atest release in the company,s newly branded Cert...p://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, D...iR-122, a microRNA Important for,Hepatitis C Viral...itis C,Virus in the Bloodstream in Chimpanzees Chr... - SPC3649 Demonstrates Efficacy With No Evidence ...in the Treated Animals - Signaling a Potential,Ben...
(Date:12/3/2009)....C., Dec. 3 In response to the increasingly criti... the evolving healthcare delivery system, Duke Med...matics (DCHI) to provide a campus focus for health...rdisciplinary approach to education that will prod...lthcare administrators with an expertise in the us...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 1With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 1Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 2Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 4
...15 Pre-mixed insulin,analogues, a modified form o...ffective than long-acting analogues for controllin...with type 2 diabetes, according to a report,funded..., part of the U.S.,Department of Health and Human ...however, appears to be equally,effective as pre-mi...
.... 15 , -- Results inconclusive, as primary outcom...ther donepezil or AZD3480; results impacted by ...own on secondary outcome measures ADCS-CGIC and MM...mparable to placebo, with fewer GI-related AEs...alysis of full dataset and planned discussions...
Other Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
Teardrop punch, Left
Meniscus Screw
Biosteon™ (HA/PLLA) Wedge Interference Screws
Graft Workstation
Medicine Products: